SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Rigel Pharmaceuticals, Inc. (RIGL)
An SI Board Since November 2000
Posts SubjectMarks Bans Symbol
566 39 0 RIGL
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
366Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-scaram(o)uche-6/3/2008
365Rigel to Host Conference Call to Discuss Preliminary Phase 2 Study Results of R7mopgcw-6/3/2008
364>> up 24% in the last reporting period << OK, so lotsa pukin' sscaram(o)uche-5/21/2008
363looks like the R788 lymphoma presentation will be Thursday, June 8...... TAMATIscaram(o)uche-5/20/2008
362Certain that most noted this, but short interest was up 24% in the last reportinscaram(o)uche-5/15/2008
361Rigel Announces First Quarter 2008 Financial Results Tuesday May 6, 7:30 am ET mopgcw-5/6/2008
360Transplantation. 2008 Mar 27;85(6):885-92. Novel Immunosuppression: R348, a JAKscaram(o)uche-5/2/2008
359<i>human disease is a moving target, patient to patient.</i> Maybe Biomaven-4/30/2008
358It's considered excellent. Next breath..... seems like the human diseasescaram(o)uche-4/30/2008
357<i>murine lupus </i> Any clue how good a model of human lupus this Biomaven-4/29/2008
356Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies Tuesdascaram(o)uche-4/29/2008
355Arthritis & Rheumatism 58: 1433 - 1444 An orally bioavailable spleen tyrosiscaram(o)uche-4/29/2008
354Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model Tuesday Aprmopgcw-4/29/2008
353interesting discussion reference and thread: Message 24533328 Message 24535436mopgcw-4/26/2008
352OK, thanks! Rickscaram(o)uche-4/12/2008
351Rick, Prior to the 3/24 announcement, Volume had consistently been above 1.1m sIan@SI-4/12/2008
350I'm confused. Volume is down, relative to the last 50 day average. Wednesdscaram(o)uche-4/11/2008
349Last one of these I'll post here. It looks like we're moving toward morIan@SI-4/11/2008
348RIGL-Q Volume exceeds 50-day average volume. 2:53 PM 10/04/2008 Some data delaIan@SI-4/10/2008
347RIGL-Q Volume exceeds 50-day average volume. 2:26 PM 8/04/2008 Some data delaIan@SI-4/8/2008
346Rigel's R788 Shows Preclinical Activity in Type 1 Diabetes Model Tuesday Aprmopgcw-4/8/2008
345[R348, a JAK3- and Syk-Inhibitor Attenuates Acute Cardiac Allograft Rejection] tuck-3/26/2008
344>> these ride-along, ignorant shorts << Not implying that there arescaram(o)uche-3/20/2008
343Yup, same molecule! Thanks, George. I remembered the old HCV program, but didnscaram(o)uche-3/20/2008
342really bugs me when these ride-along, ignorant shorts get to thumb their noses ascaram(o)uche-3/20/2008
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News